U.S. Bancorp notched a rise in earnings for the latest quarter as it benefited from a lower loan-loss provision and growth in fee income. The healthcare-products maker trimmed and narrowed its ...

Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

Dow Jones Top Company Headlines at 11 AM ET: Meta Directors, Shareholders Settle Privacy Suit Before Board Members Testify at Trial | FDA ... Meta Directors, Shareholders Settle Privacy Suit Before ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

PepsiCo logged higher revenue in the second-quarter despite a small drop in volumes.

The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...

The industry has long boasted healthy and steady growth rates. Critically, Zoetis also boasts high and improving levels of profitability.

Pfizer, in partnership with Bristol Myers Squibb, has launched a direct-to-patient sales strategy for Eliquis®, aiming to ...

Digging into the specifics of earnings season, how quarterly reports work, and how to use options players to capitalize on the events ...

Abbott on Thursday forecast third-quarter profit below Wall Street expectations and estimated about $200 million in annual tariff costs.

Merck & Co. faces headwinds despite being labeled an undervalued stock. Morgan Stanley recently lowered its price target to ...